Biosite ramps up Triage cardiac panel:
This article was originally published in Clinica
Biosite Diagnostics said that it has resolved its manufacturing problems that had prevented it meeting demand for its Triage Cardiac System emergency room heart attack detection kit. The San Diego company's product monitors the ratio of creatinine kinase, Troponin I and myoglobin. The company claims that accurate diagnosis of chest pains can have both health and economic benefits. The hand-held Triage test provides results in "about 15 minutes".
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.